Ampio Pharma has a new corp sec

Mark McGregor yesterday began his new role as the chief financial officer and corporate secretary of Ampio Pharmaceuticals, a $49 million Colorado-based drug developer.

McGregor replaces Bruce Miller, who had served as the company’s CFO and corporate secretary since April 2010 and will be working toward the commercialization of a product that Ampio obtained through its acquisition of DMI BioSciences.

A certified public accountant, McGregor boasts extensive experience in several areas, including risk management and SEC reporting, according to a press release. His 30-year career includes a stint as the vice president, corporate treasurer and corporate development at Storage Technology Corporation, a public company with $2 billion in annual worldwide revenues.


You must be registered to comment.

Please Sign In or Register.